“Our investigation confirms the harmful effect of alcohol consumption on cancer risk, but suggests that alcohol only ...
Nasal cancer, a rare but increasing cancer, affects men more than women. It originates in the nasal cavity or sinuses. Risk ...
Phase III trial shows proton therapy improves survival, reduces side effects for head and neck cancer patients.
Promising data show a median overall survival of 18.6 months, with 40% of patients alive at 2 years.Results suggest that nuclear GSK-3β ...
The combination was well tolerated: no treatment-related deaths occurred, and only 6% (2 patients) were discontinued due to ...
Mandibular reconstruction plays a pivotal role in restoring anatomy and function following ablative surgery for head and neck ...
As Lexy Thornberry fights her battle against head and neck cancer, her fiancee and professional boxer David Nyika dedicated ...
IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, is pleased to ...
Every year in biopharma brings its share of grueling defeats, and 2025 was no different, especially for companies targeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results